Photo by Kanchanara on Unsplash
Thesis: NSE's imminent DRHP filing — backed by 15.98% revenue growth, a 5.8x surge in operating cash flow, and a regulatory slate wiped clean after a decade — represents one of India's most consequential capital markets events in years. The OFS-only structure and unresolved governance legacy are the legitimate counterweights any serious researcher should price in before forming a view.
One Number That Reframes the Story
₹23,836 crore. That is the National Stock Exchange of India's operating cash flow for FY25 — up from ₹4,091 crore the prior year, a roughly 5.8x surge in a single reporting period that is difficult to categorize as routine. As of June 14, 2026, according to Business Standard, NSE is preparing to file its Draft Red Herring Prospectus (DRHP — the regulatory document that formally launches the public listing review process) with SEBI on June 15 or 16, 2026. Google News surfaced the timeline through Rediff reporting; Business Standard confirmed the specific filing window and the sequential regulatory chain that precedes it: SEBI issued its No Objection Certificate on January 30, 2026, and NSE's board formally approved the IPO plan on February 6, 2026.
The path to this moment was not direct. NSE first attempted a public listing in December 2016 before a co-location scandal — in which select brokers allegedly gained unfair trading advantages through privileged server proximity — stalled proceedings for nearly a decade. SEBI closed the case in September 2024 without adverse directions, citing insufficient evidence for conclusions, clearing the principal regulatory obstacle. The exchange that operates the NIFTY 50 index and facilitates the majority of Indian equity trading by volume is, finally, about to become a publicly traded equity itself.
The Bull Case — Three Financial Engines
The FY25 revenue picture is the foundation. As of June 14, 2026, according to Business Standard and Goodreturns, NSE reported total revenue of ₹17,141 crore for FY25, a 15.98% increase from ₹14,780 crore in FY24. Q2 FY26 extended the momentum: net profit of ₹2,613 crore, a 16% jump quarter-over-quarter.
Chart: NSE total revenue grew 15.98% year-over-year from FY24 to FY25, per Business Standard. As of June 14, 2026.
Three structural engines drive that trajectory. First, transaction fees anchored in trading volume dominance — in 2024 alone, NSE led global IPO markets by facilitating 268 listings that raised ₹1.67 lakh crore collectively. Second, co-location and low-latency data services: the infrastructure that algorithmic and high-frequency trading firms depend on, a segment that scales with automation adoption and is increasingly connected to AI-driven execution systems. Third, index licensing revenue from NIFTY 50 derivatives, a product with global reach that insulates NSE's top line from purely domestic market cycles.
As of June 14, 2026, according to BusinessToday's pre-DRHP valuation analysis, unlisted market transactions price NSE in the ₹4.7-5.5 trillion (₹5-6 lakh crore) range — which market analysts describe as potentially placing this among the largest listings in Indian capital market history. The IPO itself is structured entirely as an Offer for Sale (OFS), meaning existing shareholders sell down approximately 5% of total stake, and NSE raises zero fresh capital. Goodreturns' shareholder breakdown identifies Life Insurance Corporation at 10.72% (the single largest holder), Stock Holding Corporation at 4.44%, SBI Capital Markets at 4.33%, and State Bank of India at 3.23%. ChrysCapital, Temasek, and CPPIB are also among the expected selling shareholders.
NSE's CEO guidance of a 7-8 month timeline from the January 2026 NOC to market debut points toward a late 2026 listing date. This timing dynamic — regulatory clearance to listing window — echoes the pattern Smart Finance AI flagged in its KOSPI volatility analysis: exchange-linked instruments in emerging markets can carry structural risks that only become visible after the listing event, not before.
The Bear Case Deserves Better Than a Paragraph
My read: the bear case here is real, and the current coverage cycle is underweighting it.
Start with structure. An OFS-only IPO channels every rupee raised to selling shareholders — not to NSE's business. Temasek and CPPIB are among the world's most sophisticated institutional capital allocators. They held these stakes through the co-location scrutiny years and are choosing to reduce exposure at a ₹5-6 lakh crore valuation, after a period in which unlisted market analysts note NSE's valuation surged 201% in 2024. The question worth researching: what ceiling are experienced sellers pricing that retail participants might not be?
The governance chapter has not cleanly closed. SEBI disposed of the co-location case in September 2024 citing "insufficient evidence for conclusions" — a phrase that is legally meaningful but not equivalent to exoneration. The exchange spent nearly a decade under investigation for a scandal involving differential market access, and the IPO market is now being asked to assign a multi-trillion rupee premium to a business only recently returned to regulatory good standing. That premium bakes in continued trust that deserves ongoing monitoring, not a one-time assumption.
Valuation comparability is the third concern worth addressing seriously. BusinessToday's comparative analysis of NSE against BSE (the Bombay Stock Exchange, India's other major exchange) and global exchange peers suggests the ₹5-6 lakh crore target represents a meaningful multiple premium. For an exchange with dominant domestic market share but limited international revenue diversification, sustaining that premium requires sustained volume growth — a metric directly tied to Indian retail participation rates, which have demonstrated cyclical volatility. And Bloomberg's March 2026 reporting added a post-listing supply dynamic: thousands of NSE unlisted shareholders were contacted about a one-year holding requirement (shares held since June 15, 2025) to qualify for IPO participation. As of June 14, 2026, according to Bloomberg, that population of approximately 180,000 unlisted shareholders represents a diffuse seller base whose post-lock-up behavior could create supply pressure that institutional allocation models may not fully capture.
Watchlist — Metrics and Dates Worth Tracking
DRHP filing date: June 15-16, 2026. The document itself will be the first public disclosure of NSE's complete financials, risk factors, and shareholder sell quantities. Reading the DRHP directly — particularly the risk factors section — is where investment research on this listing should start, not end.
SEBI review window. SEBI's standard observation period runs 30-75 days from DRHP submission. A clean review with no additional queries supports a Q3 2026 roadshow; any SEBI information requests would likely push the debut toward early 2027, materially altering the market timing thesis.
BSE (ticker: BSE.NS) is the closest publicly traded Indian comparable. Monitoring BSE's revenue multiple and P/E ratio (stock price divided by earnings per share) in the weeks following NSE's DRHP filing provides a real-time benchmark for whether the market is expanding or contracting its willingness to pay for Indian exchange infrastructure. Convergence or divergence between the two will sharpen any relative valuation framework.
LIC (LICI.NS) and SBI (SBIN.NS) — the two largest public-sector holders — are worth watching for any regulatory filings or announcements about the specific volume of shares they intend to offer. OFS float size drives oversubscription dynamics and early price discovery more than almost any other variable at the listing stage.
Operating cash flow verification. FY25's ₹23,836 crore versus FY24's ₹4,091 crore is the single most compelling fundamental data point in the pre-IPO file, and the most important unresolved question: whether that inflection is structural (a permanent step-change in the fee model or trading volumes) or one-time (a working capital release or accounting reclassification). The DRHP's cash flow statement will answer it.
Frequently Asked Questions
When is the NSE IPO expected to list on Indian stock exchanges?
As of June 14, 2026, NSE's CEO publicly indicated a 7-8 month timeline from the SEBI No Objection Certificate received January 30, 2026, which implies a late 2026 market debut. That estimate assumes the DRHP filed June 15-16 clears SEBI review — typically 30-75 days — without additional queries. No official listing date has been confirmed.
What is the expected NSE IPO valuation and price range?
As of June 14, 2026, according to BusinessToday and Goodreturns, unlisted market transactions value NSE in the ₹4.7-5.5 trillion (₹5-6 lakh crore) range. The IPO size is expected at ₹21,000-24,500 crore (approximately $2.75 billion USD). An official price band will only be disclosed in the final Red Herring Prospectus, after SEBI reviews the DRHP.
Is the NSE IPO a good investment opportunity, and what should researchers examine?
The NSE IPO presents data points worth researching on both sides. The bull case includes 15.98% FY25 revenue growth (₹17,141 crore), a 16% Q2 FY26 net profit jump to ₹2,613 crore, and infrastructure monopoly economics in India's largest equity market. The bear case includes an OFS-only structure (institutional sellers cashing out), a decade of governance history, a 201% valuation surge that prices in significant optimism, and potential post-lock-up supply from approximately 180,000 unlisted shareholders. This is not financial advice — all investment decisions should follow independent research and consultation with a licensed financial advisor.
Who are NSE's major shareholders, and how much stake is being sold in the IPO?
As of June 14, 2026, according to Goodreturns, Life Insurance Corporation holds 10.72% (largest single stakeholder), Stock Holding Corporation holds 4.44%, SBI Capital Markets holds 4.33%, and State Bank of India holds 3.23%. ChrysCapital, Temasek, and CPPIB are also identified as expected selling shareholders. The OFS targets approximately 5% total stake dilution. Precise per-shareholder quantities will be disclosed in the DRHP, filed June 15-16, 2026.
Explore Our Network
Disclaimer: This article is for educational and informational purposes only. It does not constitute financial advice, a recommendation, or an endorsement of any security. Always do your own research and consult a licensed financial advisor before making investment decisions. Research based on publicly available sources current as of June 14, 2026.
No comments:
Post a Comment